ENLIVEN THERAPEUTICS, INC. (ELVN) Capital expenditures 2019–2025
ENLIVEN THERAPEUTICS, INC. (ELVN) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$158,000FY2025 · since FY2019: $140,000 → $158,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $158,000 | +259.1% |
| FY2024 | $44,000 | -70.5% |
| FY2023 | $149,000 | -75.7% |
| FY2022 | $612,000 | +5000.0% |
| FY2021 | $12,000 | -33.3% |
| FY2020 | $18,000 | -87.1% |
| FY2019 | $140,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice